Form 4: Cryo-Cell International Director Acquires Stock Options
SEC Form 4 Filing
Harold Berger, a director at Cryo-Cell International, acquired stock options for 5,300 shares of common stock at an exercise price of $5.82 on October 29, 2024.
Summary
- On October 29, 2024, Harold Berger, a director of Cryo-Cell International Inc. (CCEL), acquired stock options for 5,300 shares of common stock.
- The exercise price for these options is $5.82 per share.
- These options vest at a rate of 1/12 per month commencing on October 29, 2024, and expire on October 29, 2034.
- Following this transaction, Berger directly owns options for 7,500 shares at $3.08, 7,500 shares at $7.53, 5,300 shares at $7.74, 5,300 shares at $7.85, 5,300 shares at $12.63, 5,300 shares at $6.5, 5,300 shares at $4.9 and 5,300 shares at $5.82.
- Berger also directly owns 50,401 shares of common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock option acquisition by a director. While insider buying can be seen as positive, option grants are part of compensation and don't necessarily indicate strong bullish sentiment.
Positives
- A director's acquisition of stock options could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, like directors, trade in their company's stock; they provide transparency to the market.
Stakeholder Impact
- Shareholders may view the director's stock option acquisition as a sign of confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 07/09/2015 | Date of exercisable for stock options with an expiration date of 07/09/2025 and an exercise price of $3.08. |
| 08/30/2019 | Date of exercisable for stock options with an expiration date of 08/30/2029 and an exercise price of $7.53. |
| 11/25/2019 | Date of exercisable for stock options with an expiration date of 11/25/2029 and an exercise price of $7.74. |
| 09/22/2020 | Date of exercisable for stock options with an expiration date of 09/22/2030 and an exercise price of $7.85. |
| 10/20/2021 | Date of exercisable for stock options with an expiration date of 10/20/2031 and an exercise price of $12.63. |
| 10/03/2022 | Date of exercisable for stock options with an expiration date of 10/03/2032 and an exercise price of $6.5. |
| 10/10/2023 | Date of exercisable for stock options with an expiration date of 10/10/2033 and an exercise price of $4.9. |
| 10/29/2024 | Date of transaction and commencement of vesting for new stock options with an expiration date of 10/29/2034 and an exercise price of $5.82. |
| 10/29/2034 | Expiration date of the newly acquired stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.